Hmm: Authors retract paper rather than allow discussion of politics of organ donation in China

transplantationOrgan donation in China, particularly the practice of using organs from executed prisoners, which the government pledged to stop by the middle of this year, has been a controversial subject. For a group of authors in that country and the U.S, a letter criticizing their work that introduced “the political situation of organ donation in China” was cause to retract their own paper.

Here’s the notice in question from Transplantation, for a study published three months ago: Continue reading Hmm: Authors retract paper rather than allow discussion of politics of organ donation in China

Weekend reads: Publish a paper, get $10,000!; Lancet editor Horton under fire

booksAnother busy week at Retraction Watch. Here’s what was happening elsewhere:

Continue reading Weekend reads: Publish a paper, get $10,000!; Lancet editor Horton under fire

“Research misconduct accounts for a small percentage of total funding”: Study

elifeHow much money does scientific fraud waste?

That’s an important question, with an answer that may help determine how much attention some people pay to research misconduct. But it’s one that hasn’t been rigorously addressed.

Seeking some clarity,  Andrew Stern, Arturo Casadevall, Grant Steen, and Ferric Fang looked at cases in which the Office of Research Integrity had determined there was misconduct in particular papers. In their study, published today in eLife: Continue reading “Research misconduct accounts for a small percentage of total funding”: Study

University of Maryland duo notches third retraction

Anil Jaiswal, via U Maryland
Anil Jaiswal, via U Maryland

A pair of researchers at the University of Maryland have retracted a third paper.

Here’s the unhelpful Journal of Biological Chemistry notice for “Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis,” by Suryakant Niture and Anil Jaiswal: Continue reading University of Maryland duo notches third retraction

Cell retraction of Alzheimer’s study is second for Tufts neuroscientist

Domnez_Gizem
Gizem Donmez, via Tufts

A researcher at Tufts University has retracted a paper in Cell, a year after retracting a study on a similar subject from the Journal of Biological Chemistry.

Here’s the notice for “SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10,” a 2010 paper by Tufts’ Gizem Donmez, MIT’s Leonard Guarante — of longevity research fame — and colleagues: Continue reading Cell retraction of Alzheimer’s study is second for Tufts neuroscientist

“Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”

regional sci policy practiceWe’re going to get a little meta here, so be warned.

Take a look at the headline of this post. For those of you unfamiliar with the symbols to the left and right of the words, those are quotation marks. What that means is that we’ve taken those two sentences from another source. And here is that other source, a blog post from Tahseen Consulting titled — yes, you guessed it, “Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”

Apparently, the last group of authors who liked Tahseen’s words enough to use them did so without that whole attribution thing. Here, let us demonstrate attribution again, this time using the WordPress block-quote function. From the post: Continue reading “Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”

Authors retract highly cited XMRV-prostate cancer link paper from PNAS

pnas 1113Retraction Watch readers may recall that nearly two years ago, an editor at PLOS declared the scientific story of a link between XMRV, aka xenotropic murine leukemia-related virus, and prostate cancer over, saying that a retraction from PLOS Pathogens was the “final chapter.” (That retraction led to an apology from the journal about how it was handled.)

Perhaps, however, there is an epilogue. This week, a group of authors who published a highly cited 2009 study in the Proceedings of the National Academy of Sciences (PNAS) making the same link retracted it. Here’s the notice, signed by all five authors: Continue reading Authors retract highly cited XMRV-prostate cancer link paper from PNAS

Weekend reads: Women in science, creative peer review, is civil discourse about science still possible?

booksAnother busy week at Retraction Watch. Here’s what was happening elsewhere: Continue reading Weekend reads: Women in science, creative peer review, is civil discourse about science still possible?

On vigorous scientific debates, witch hunts, and the tragedy of suicide

logoThe suicide earlier this week of Yoshiki Sasai, one of the scientists who worked on the now-discredited STAP stem cell work, was a startling and sobering reminder to the research community and the public that misconduct can take a heavy human toll – even on people like Sasai, whom by all accounts only had the misfortune of working with a dishonest colleague.

The tension surrounding this case and others was well-captured by University of California, Berkeley biologist Michael Eisen, who himself lost his father, also a scientist, to suicide in 1987 in a case that he said had haunting parallels to Sasai’s:

Obviously, fraud is a terrible thing. Nothing provides as deep an existential threat to the scientific enterprise than making up data. But as bad as it is, there is something deeply ugly about the way the scientific community responds to misconduct. We need to deal swiftly with fraud when it is identified. But time after time I have watched the way not only the accused, but everyone around them, is treated with such sanctimonious disdain it is frankly not surprising that some of them respond in tragic ways.

Some of the commenters on Eisen’s post, as well as here on Retraction Watch, have had questions like this: Continue reading On vigorous scientific debates, witch hunts, and the tragedy of suicide

STAP stem cell co-author commits suicide: Reports

Yoshiki Sasai, via RIKEN
Yoshiki Sasai, via RIKEN

In a stunning and tragic development, a co-author of the now-retracted Nature papers claiming to have found an easy way to create stem cells has committed suicide, according to news reports in Japan.

According to the Japan Times, RIKEN deputy director Yoshiki Sasai has died: Continue reading STAP stem cell co-author commits suicide: Reports